ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
NeOnc Technologies Holdings
6.05
-0.3800
-5.91%
成交量:
4.28萬
成交額:
25.96萬
市值:
1.13億
市盈率:
-8.77
高:
6.59
開:
6.31
低:
5.82
收:
6.43
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
NeOnc Technologies Holdings
交易所:
NASDAQ
成立時間:
2008
員工人數:
- -
公司地址:
Two Dole Drive,Westlake Village,California,United States
官網:
http://www.neonctech.com
郵編:
91362
電話:
310-663-7831
傳真:
- -
簡介:
Neonc Technologies Holdings, Inc.於2023年1月5日註冊成立,為特拉華州公司。作為一家臨床階段的生物製藥公司,該公司一直專註於建立顱內惡性腫瘤的治療方法,即位於大腦的侵襲性癌症。這些癌症類型包括原發性腦癌,如膠質母細胞瘤,和繼發性腦癌,它們是通過全身其他癌症的轉移擴散而來的,如黑色素瘤或乳腺癌和肺癌。大腦局限性惡性腫瘤特別難以治療,因為血腦屏障阻止了大多數藥物治療劑有效進入大腦。因此,這些患者面臨着預后不良和平均預期壽命縮短的問題。NeOnc正在開發新的藥物遞送方法,用於與新的候選藥物聯合使用。
董事
名稱
職位
Amir Heshmatpour
Executive Chairman and Secretary
Thomas C. Chen
Chief Executive Officer and Chairman
Keithly Garnett
Chief Financial Officer and Director
Bader Almonawer
Director
Jim Delshad
Director
Ming Fu Chiang
Director
Steven L. Giannotta
Director
Victoria Medvec
Director
股東
名稱
職位
Thomas C. Chen
Chief Executive Officer and Chairman
Patrick Walters
Chief Operating Officer
Keithly Garnett
Chief Financial Officer and Director
Amir Heshmatpour
Executive Chairman and Secretary
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NTHI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":6.05,"timestamp":1745345381038,"preClose":6.43,"halted":0,"volume":42800,"delay":0,"floatShares":5219711,"shares":18745865,"eps":-0.69,"marketStatus":"交易中","change":-0.38,"latestTime":"04-22 14:11:37 EDT","open":6.31,"high":6.5887,"low":5.82,"amount":259593.83848,"amplitude":0.119549,"askPrice":6.11,"askSize":100,"bidPrice":5.9,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-0.69,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":6.43,"preHourTrading":{"tag":"盘前","latestPrice":6.2,"preClose":6.43,"latestTime":"09:29 EDT","volume":3,"amount":19.149999,"timestamp":1745328598412},"postHourTrading":{"tag":"盘后","latestPrice":6.32,"preClose":6.32,"latestTime":"16:05 EDT","volume":2,"amount":12.86,"timestamp":1745265912201},"volumeRatio":1.118741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":5219711,"roa":"-189.56%","roe":"--","lyrEps":-0.686076,"volumeRatio":1.118741,"shares":18745865,"dividePrice":0,"high":6.5887,"amplitude":0.119549,"preClose":6.43,"low":5.82,"week52Low":5.82,"pbRate":"-20.60","psRate":"1366.42","week52High":25,"institutionHeld":0,"latestPrice":6.05,"committee":-0.666667,"eps":-0.69,"divideRate":0,"volume":42800,"delay":0,"ttmEps":-0.69,"open":6.31,"prevYearClose":25,"prevWeekClose":6.95,"prevMonthClose":13.36,"prevQuarterClose":13.36,"fiveDayClose":7.95},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1847121177,"yearFounded":2008,"address":"Two Dole Drive,Westlake Village,California,United States","zipCode":"91362","officePhone":"310-663-7831"},"stockCompanyDetail":{"websiteUrl":"http://www.neonctech.com","stockEarnings":[{"period":"1week","weight":-0.205},{"period":"1month","weight":-0.7472},{"period":"ytd","weight":-0.7472}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Neonc Technologies Holdings, Inc.於2023年1月5日註冊成立,為特拉華州公司。作為一家臨床階段的生物製藥公司,該公司一直專註於建立顱內惡性腫瘤的治療方法,即位於大腦的侵襲性癌症。這些癌症類型包括原發性腦癌,如膠質母細胞瘤,和繼發性腦癌,它們是通過全身其他癌症的轉移擴散而來的,如黑色素瘤或乳腺癌和肺癌。大腦局限性惡性腫瘤特別難以治療,因為血腦屏障阻止了大多數藥物治療劑有效進入大腦。因此,這些患者面臨着預后不良和平均預期壽命縮短的問題。NeOnc正在開發新的藥物遞送方法,用於與新的候選藥物聯合使用。","exchange":"NASDAQ","name":"NeOnc Technologies Holdings","nameEN":"NeOnc Technologies Holdings"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":{"directors":[{"name":"Amir Heshmatpour","position":"Executive Chairman and Secretary"},{"name":"Thomas C. Chen","position":"Chief Executive Officer and Chairman"},{"name":"Keithly Garnett","position":"Chief Financial Officer and Director"},{"name":"Bader Almonawer","position":"Director"},{"name":"Jim Delshad","position":"Director"},{"name":"Ming Fu Chiang","position":"Director"},{"name":"Steven L. Giannotta","position":"Director"},{"name":"Victoria Medvec","position":"Director"}],"executives":[{"name":"Thomas C. Chen","position":"Chief Executive Officer and Chairman"},{"name":"Patrick Walters","position":"Chief Operating Officer"},{"name":"Keithly Garnett","position":"Chief Financial Officer and Director"},{"name":"Amir Heshmatpour","position":"Executive Chairman and Secretary"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2025-04-17","current":-11.028403,"percent":0.9375,"low":-26.074295,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"high":-11.028403,"avg":-16.351317,"sd":3.867449,"marketCap":131221055},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055}],"updateTime":1745310140843}}}